3-rx.comCustomer Support
HomeAbout UsFAQContactHelp
News Center
Health Centers
Medical Encyclopedia
Drugs & Medications
Diseases & Conditions
Medical Symptoms
Med. Tests & Exams
Surgery & Procedures
Injuries & Wounds
Diet & Nutrition
Special Topics

\"$alt_text\"');"); } else { echo"\"$alt_text\""; } ?>

Join our Mailing List


You are here : 3-RX.com > Home > Cancer - Breast Cancer -

CTRC, AACR and Baylor College of Medicine to Host San Antonio Breast Cancer Symposium

Cancer • • Breast CancerNov 04, 09

Now in its 32nd year, the CTRC-AACR San Antonio Breast Cancer Symposium remains the top venue for research and discovery in breast cancer. This year’s conference will bring together delegates from all over the world. Among the expected highlights:
• Five-year results of the groundbreaking Herceptin trial.
• Definitive data on the role of bisphosphonates in breast cancer prevention.
• The role hormone therapies may play in lung cancer treatment.
• New data on the role of obesity and alcohol in breast cancer risk.
• Emerging therapies that could change the treatment landscape.

To help you plan your coverage of the conference, the program schedule is available online at http://www.sabcs.org. Although the full abstracts will not be available online until the conference begins, an electronic press kit containing the press releases and select highlighted abstracts will be available on Dec. 2, 2009 to reporters registered through the AACR and those with a subscription to Eurekalert and/or Newswise.

More than 2,000 abstracts will be presented for the first time at the conference, complementing an outstanding program of scientific and educational events. The CTRC-AACR San Antonio Breast Cancer Symposium attracts world leaders in cancer research and treatment, including clinical oncologists, industry leaders, basic scientists and translational researchers who are working to improve patient care with the ultimate goal of eradicating breast cancer.

Dec. 9-13, 2009

Henry B. Gonzales Convention Center
San Antonio, Texas

Press Registration/Contact:
Emma O’Brien
(267) 646-0613
.(JavaScript must be enabled to view this email address)


Source:  American Association for Cancer Research (AACR)

Print Version
comments powered by Disqus

  New biomarkers may influence drug design and alternative treatments of cancer, study shows
  Metabolic profiles distinguish early stage ovarian cancer with unprecedented accuracy
  Moffitt researchers develop first genetic test to predict tumor sensitivity to radiation therapy
  New drug for neuroblastoma shows promise in phase I study
  Experimental treatment sends deadly leukemia into remission
  Study could reduce unnecessary cancer screening
  UA researchers discover component of cinnamon prevents colorectal cancer in mice
  Profiling approach to enable right lung cancer treatment match
  Fat grafting technique improves results of breast augmentation
  Germline TP53 mutations in patients with early-onset colorectal cancer
  Clinical trial suggests combination therapy is best for low-grade brain tumors
  UW research shows sensor technology may help improve accuracy of clinical breast exams


Home | About Us | FAQ | Contact | Advertising Policy | Privacy Policy | Bookmark Site